| scholarly article | Q13442814 |
| P50 | author | Gian Maria Rossolini | Q28323988 |
| Francesco Luzzaro | Q38640711 | ||
| Tommaso Giani | Q42872280 | ||
| Elisabetta Nucleo | Q56487481 | ||
| Roberta Migliavacca | Q56487483 | ||
| Laura Pagani | Q56487485 | ||
| Marco Maria D'Andrea | Q56704881 | ||
| P2093 | author name string | Vesselina Kroumova | |
| Francesca Vailati | |||
| P2860 | cites work | Plasmid-determined AmpC-type beta-lactamases | Q24535748 |
| Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat | Q24550671 | ||
| beta-Lactamases in laboratory and clinical resistance | Q24669605 | ||
| A functional classification scheme for beta-lactamases and its correlation with molecular structure | Q24677460 | ||
| Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
| Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals | Q33554703 | ||
| Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs | Q34104453 | ||
| AmpC beta-lactamases: what do we need to know for the future? | Q35140531 | ||
| DNA polymorphisms amplified by arbitrary primers are useful as genetic markers | Q35888035 | ||
| Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy | Q35922116 | ||
| DNA sequence analysis of regions surrounding blaCMY-2 from multiple Salmonella plasmid backbones. | Q36670559 | ||
| CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid. | Q36670970 | ||
| CFE-1, a novel plasmid-encoded AmpC beta-lactamase with an ampR gene originating from Citrobacter freundii | Q37118636 | ||
| Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland | Q37598717 | ||
| Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase. | Q39470864 | ||
| Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis | Q39558426 | ||
| Emerging extended-spectrum beta-lactamases in Proteus mirabilis | Q39697527 | ||
| Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. | Q39746711 | ||
| Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C beta-lactamase gene in Escherichia coli BS. | Q39866955 | ||
| Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. | Q40469507 | ||
| DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting | Q40534615 | ||
| CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). | Q43726434 | ||
| Identification of plasmid-encoded cephalosporinase ACC-1 among various enterobacteria (Klebsiella pneumoniae, Proteus mirabilis, Salmonella) isolated from a Tunisian hospital (Sfax 997-2000) | Q43902168 | ||
| Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals | Q43991111 | ||
| Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins | Q46367321 | ||
| Plasmid-mediated, inducible AmpC beta-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis | Q46528100 | ||
| Characterization of CMY-type beta-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area. | Q46542480 | ||
| First description of DHA-1 ampCbeta-lactamase in Proteus mirabilis | Q46556698 | ||
| Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis | Q47998778 | ||
| Hybridization of nucleic acids directly in agarose gels | Q72711217 | ||
| Plasmid-mediated cephalosporinase ACC-1 in clinical isolates of Proteus mirabilis and Escherichia coli | Q73383813 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Italy | Q38 |
| Proteus mirabilis | Q311273 | ||
| P304 | page(s) | 618-624 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy | |
| P478 | volume | 50 |
| Q37366249 | AmpC beta-lactamases |
| Q64135908 | AmpC β-lactamase-producing Enterobacterales: what a clinician should know |
| Q33755384 | Biofilm is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug Resistant Phenotype |
| Q37287849 | Characterization of CTX-M-140, a Variant of CTX-M-14 Extended-Spectrum β-Lactamase with Decreased Cephalosporin Hydrolytic Activity, from Cephalosporin-Resistant Proteus mirabilis |
| Q48079150 | Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 beta-lactamases |
| Q40601639 | Chromosomal integration and location on IncT plasmids of the blaCTX-M-2 gene in Proteus mirabilis clinical isolates. |
| Q34108605 | Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate. |
| Q34737727 | Chromosome-encoded AmpC and CTX-M extended-spectrum β-lactamases in clinical isolates of Proteus mirabilis from Korea |
| Q52359703 | Colonization of long-term care facility residents in three Italian Provinces by multidrug-resistant bacteria. |
| Q36439133 | Cooccurrence of Multiple AmpC β-Lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis in Tunisia |
| Q35065751 | Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil |
| Q36573826 | Draft Genome Sequence of Proteus mirabilis NO-051/03, Representative of a Multidrug-Resistant Clone Spreading in Europe and Expressing the CMY-16 AmpC-Type β-Lactamase |
| Q33601560 | Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2. |
| Q39525501 | Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities |
| Q35005180 | Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe |
| Q35806283 | Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit |
| Q40087078 | Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients |
| Q33899961 | Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. |
| Q90176593 | Genetics of Acquired Antibiotic Resistance Genes in Proteus spp |
| Q36290815 | In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime |
| Q37336188 | Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit |
| Q46986700 | Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings |
| Q36744818 | Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals |
| Q36895636 | New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting |
| Q34623275 | Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities |
| Q37247631 | Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase |
| Q43791115 | Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones |
| Q58797117 | Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens |
| Q93264979 | The resistomes of six carbapenem-resistant pathogens - a critical genotype-phenotype analysis |
| Q37716730 | Virulence and Genomic Feature of a Virulent Klebsiella pneumoniae Sequence Type 14 Strain of Serotype K2 Harboring blaNDM-5 in China |
Search more.